Get the app
US › Healthcare

Avita Medical Ltd (RCEL)

US · Healthcare · Medical Devices

$11.22+7.37%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$21.7M
Revenue YoY
+17.8%
Net profit
$-7.7M
EPS
$-0.25
EPS estimate
$-0.39
Net margin
-35.3%

EPS came in at -0.25 against a street estimate of -0.39 — a beat of 35.9%.

Key statistics

Market cap
$305.6M
Forward P/E
10.3
P/B
11.77
Book value
$-0.90
EPS (TTM)
$-1.44
52-week high
$11.39
52-week low
$3.22
50-day MA
$7.15
200-day MA
$4.89
Beta
2.02

Analyst view

Analysts rate Avita Medical Ltd a strong buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $12.48.

Shareholding

Insiders
1.52%
Institutions
16.02%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC4.32%
BlackRock Inc3.66%
Geode Capital Management, LLC1.76%
State Street Corp1.39%
Vanguard Fiduciary Trust Co0.63%
Northern Trust Corp0.59%
Morgan Stanley - Brokerage Accounts0.51%
Divisadero Street Capital Management, LP0.32%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Avita Medical Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.